SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

IBRXs high-volume rally is being linked by traders to founder Patrick Soon-Shiongs scheduled oncology fireside chat, where he is expected to discuss trial progress, as well as anticipation around bladder-cancer regulatory milestones. Speculation about a partnership, a connection to the NIH cancer-vaccine initiative, and a possible short squeeze is circulating, but those claims are unconfirmed.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflakes Agentic Marketplace Discovery launch and a bullish analyst price-target update are driving attention, alongside a broader rotation into AI-related software. Traders are highlighting the rally and potential breakout, while skeptics question the stocks valuation and profitability.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Goldman Sachs upgrade to Buy, citing Palantirs sovereign-AI and customized-software opportunities, coincided with a breakout to fresh highs. Bulls celebrate the momentum and speculate about a short squeeze, while skeptics warn that the valuation is stretched and the rally could reverse.

Datadog, Inc. engages in the development of a monitoring and analytics platform for developers, information technology operations teams and business users. Its platform integrates and automates infrastructure monitoring, application performance monitoring and log management to provide real-time observability of its customers' entire technology stack. The company was founded by Olivier Pomel and Alexis Lê-Quôc on June 4, 2010 and is headquartered in New York, NY.

Datadog Inc - Ordinary Shares - Class A

Datadog Inc

Datadog is drawing attention after a sharp rally and breakout to fresh highs alongside strength in software stocks, with traders pointing to momentum and continued interest in cloud and AI-related software. Bulls see room for the move to continue, while bears cite the stocks rich valuation and warn of a pullback.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys partnership with Metas Muse to enable AI-agent purchases through Shop Pay is fueling interest, with bulls seeing a new commerce channel and skeptics questioning how quickly it can be monetized. Traders are also debating whether the sharp rally can continue amid volatility and resistance near recent highs.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Repeated analyst price-target cuts and valuation concerns are dominating discussion around APPs sharp pullback ahead of its upcoming earnings report. Long-term bulls point to the companys ad growth, cash flow and e-commerce opportunity, while many holders are frustrated by the volatile price action and debate whether the selloff reflects deteriorating prospects or an opportunity.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorillas proposed non-binding deal for its first U.S. data center and broader AI-infrastructure expansion plan are driving discussion. Some traders welcome the U.S. growth opportunity, while many question how the capital-intensive plans will be financed and want proof of execution, raising concerns about dilution and whether the deal will close.

T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA.

T-Mobile US Inc

SpaceXs spectrum acquisition and Starlink Mobile ambitions have triggered a sharp selloff in T-Mobile shares as traders weigh the prospect of a new wireless competitor. The community is split between viewing the threat as a long-term risk to carriers and calling the reaction an overreaction given SpaceXs need to build out its network.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

A reported NIH-backed push to accelerate personalized cancer vaccines is drawing attention to Mercks role in the field, including its V940 partnership with Moderna and promising melanoma-trial results. Traders see the initiative as supportive of Mercks oncology prospects, though some caution that a research push does not guarantee near-term revenue.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

Michael Burrys disclosed QXO stake has sparked renewed attention after a prolonged share-price decline, with traders debating whether the prominent investors position could prompt short covering. Some see it as a vote of confidence in QXOs building-products roll-up, while others question whether the attention changes the companys underlying outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Brief Consumer: The A2 Milk Company Infant Formula Recall What We Know So Far and more

In this briefing: The A2 Milk Company Infant Formula Recall What We Know So Far Primer: Sampoerna Agro (SGRO IJ) - Feb 2026 Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation 1. The A2 Milk Company Infant Formula Recall What We Know So Far Newsflow has continued to increase on the global infant formula recall, and we are receiving many questions from investors. Our broad thoughts at this stage are: (1) we think The a2 Milk Company (ATM) is in the clear from any negative impacts, although we recognise why some investors are cautious; and (2) the possible China upside is hard to assess, given Danone’s China products source the problem ARA ingredient from another supplier and Nestlé’s China recall exposure is very limited. This is clearly a sensitive situation, with newsflow (and our view) likely to evolve. 2. Primer: Sampoerna Agro (SGRO IJ) - Feb 2026 Sampoerna Agro is a significant Indonesian agribusiness focused primarily on palm oil, which constitutes over 90% of its revenue.

Brief Consumer: Primer: Sampoerna Agro (SGRO IJ) - Feb 2026 and more

In this briefing: Primer: Sampoerna Agro (SGRO IJ) - Feb 2026 Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation Hybridan Small Cap Feast: 26 January 2026 1. Primer: Sampoerna Agro (SGRO IJ) - Feb 2026 Sampoerna Agro is a significant Indonesian agribusiness focused primarily on palm oil, which constitutes over 90% of its revenue. The company is geographically diversified with plantations in Sumatra and Kalimantan, mitigating localized operational risks. Financial performance is inherently cyclical, tied to volatile Crude Palm Oil (CPO) prices. While recent quarters show margin recovery, the company's longer-term earnings and cash flow metrics exhibit significant fluctuations. The forward outlook is balanced. Favorable CPO price forecasts and Indonesia's biodiesel mandates present opportunities, but these are tempered by significant risks including regulatory uncertainty in Indonesia, global ESG pressures, and the threat of substitute vegetable oils.

Brief Equities Bottom-Up: Prestige Estates Projects Ltd - Q3FY26: Record Sales, Expanding Pipeline & Annuity Ramp Up and more

In this briefing: Prestige Estates Projects Ltd - Q3FY26: Record Sales, Expanding Pipeline & Annuity Ramp Up Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation 1. Prestige Estates Projects Ltd - Q3FY26: Record Sales, Expanding Pipeline & Annuity Ramp Up Record Nine-month Performance: Prestige reported pre-sales of Rs 4,184 Cr for the quarter, registering a 39% YoY growth, surpassing the last full year, in line with expectations. Collections stood at Rs 4,548 Cr, marking the highest-ever level for the period, while 9MFY26 collections reached Rs 13,283 Cr, surpassing the collections achieved in the previous full financial year. During Q3FY26, the company launched 5 Mn sq. ft. development across three projects, including Eden Park at TPC and Prestige Tech Hub. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Growth Ideas: Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY and more

In this briefing: Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD Egypt, February 3rd 2026, KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation 1. Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY Capacity Addition to Support Volume and Revenue Growth: The company is expanding capacity from 109 MTPA (including 8.5 MTPA from Orient Cement) to 115 MTPA by FY26. It now targets 155 MTPA by FY28, supported by incremental expansion and debottlenecking initiatives. With current utilisation at 69%, there remains meaningful upside potential as demand strengthens. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Nestlé reported an 18.5% YoY growth in revenue, supported by its strongest volume expansion in nearly five years.

Brief Equities Bottom-Up: Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY and more

In this briefing: Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation NTPC - Q3 - Stable Performance Backed by Capacity Additions 1. Ambuja Cements Ltd - Performance Below Estimates On Higher Cost; Retain BUY Capacity Addition to Support Volume and Revenue Growth: The company is expanding capacity from 109 MTPA (including 8.5 MTPA from Orient Cement) to 115 MTPA by FY26. It now targets 155 MTPA by FY28, supported by incremental expansion and debottlenecking initiatives. With current utilisation at 69%, there remains meaningful upside potential as demand strengthens. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below. 2. Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Nestlé reported an 18.5% YoY growth in revenue, supported by its strongest volume expansion in nearly five years.

Brief India: Nestle India Ltd - Steller Topline Growth; Margins Under Pressure and more

In this briefing: Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation NTPC - Q3 - Stable Performance Backed by Capacity Additions National Aluminium Co Ltd (NALCO) - EBITDA Beat on Alumina Volumes; Rich Valuations Caps Upside 1. Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Nestlé reported an 18.5% YoY growth in revenue, supported by its strongest volume expansion in nearly five years. Performance was driven by double-digit growth in confectionery and MAGGI noodles, along with robust growth in beverages and prepared dishes, while the Milk & Nutrition portfolio delivered mid-single-digit growth. Management attributed the strong quarter to capacity additions, sustained brand investments, market recovery, and benefits from GST-related changes. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Consumer: Nestle India Ltd - Steller Topline Growth; Margins Under Pressure and more

In this briefing: Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation Hybridan Small Cap Feast: 26 January 2026 Hyundai Mobis (012330 KS Jan 29, 2026) - Moving in a Clear Direction 1. Nestle India Ltd - Steller Topline Growth; Margins Under Pressure Nestlé reported an 18.5% YoY growth in revenue, supported by its strongest volume expansion in nearly five years. Performance was driven by double-digit growth in confectionery and MAGGI noodles, along with robust growth in beverages and prepared dishes, while the Milk & Nutrition portfolio delivered mid-single-digit growth. Management attributed the strong quarter to capacity additions, sustained brand investments, market recovery, and benefits from GST-related changes. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief Equities Bottom-Up: Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD and more

In this briefing: Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD KPIT Technologies Ltd - Soft Quarter; Solution-Based Transformation NTPC - Q3 - Stable Performance Backed by Capacity Additions National Aluminium Co Ltd (NALCO) - EBITDA Beat on Alumina Volumes; Rich Valuations Caps Upside PICK OF THE WEEK: HCL Technologies Ltd - 31st January, 2026 1. Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD Relaxo reported a marginal 0.2% YoY revenue growth, marking a stabilisation after consecutive quarters of decline. Management attributed the improvement to ongoing sales transformation initiatives, though the mass-market environment remained subdued with cautious consumer spending during the festive season. Heightened competition from the unorganised segment led to increased promotional intensity, aiding topline recovery but pressuring margins, further impacted by higher promotional spend and a one-off cost related to the new labour code. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Brief India: Relaxo Footwears Ltd - Soft Quarter Continues; Maintain HOLD and more

Brief India: Rainbow Children’s Medicare Ltd - Steady Performance, Lower Seasonality; Maintain BUY! and more

In this briefing: Rainbow Children’s Medicare Ltd - Steady Performance, Lower Seasonality; Maintain BUY! Relaxo Footwears Ltd. - Soft Quarter, Steady Recovery Expected; Maintain HOLD VIP Industries Ltd - Weak Quarter, Near-Term Challenges Drag Profitability China’s Bank-Centric Funding: An Under-Reported Risk Allied Blenders and Distillers: The Transformation Story from Mass Market to Luxury Spirits 1. Rainbow Children’s Medicare Ltd - Steady Performance, Lower Seasonality; Maintain BUY! In Line Revenue Performance: Rainbow delivered revenue broadly in line with expectations, growing 7% YoY and recovering 26% sequentially. The quarter was largely impacted by a lower incidence of vector-borne diseases, in line with broader industry sentiment. Revenue growth remained subdued as admissions related to seasonal infections were lower. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

Relaxo Footwears Ltd. engages in the manufacture and marketing of footwear and related products. It operates through the Foot ware and Related Products segment. The company was founded in 1976 and is headquartered in Rohini, India.

Current Price	284.15
Prev Close	286.00
Open	283.90
Dividend Yield	1.47%
50-Day Moving Average	343.12
Beta	-0.07
Avg. Volume	258,619.10
PE Ratio	38.42

52-Week High	454.70
52-Week Low	236.50
Market Capitalization	70.25B
EPS (Annual)	7.20
Price to Book	3.23
Revenue Per Employee	1.31M

Feed

News

Sentiment

Earnings

Fundamentals

Info

RELAXO.NSE Fundamentals